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Abstract
To improve health outcomes in people living with HIV, adoption of evidence-based interven-
tions (EBIs) using effective and transferable implementation strategies to optimise the deliv-
ery of healthcare is needed. ViiV Healthcare’s Positive Pathways initiative was established
to support the UNAIDS 90-90-90 goals. A compendium of EBIs was developed to address
gaps within the HIV care continuum, yet it was unknown whether efforts existed to adapt
and implement these EBIs across diverse clinical contexts. Therefore, this review sought to
report on the use of implementation science in adapting HIV continuum of care EBIs. A sys-
tematic literature review was undertaken to summarise the evaluation of implementation
and effectiveness outcomes, and report on the use of implementation science in HIV care.
Ten databases were reviewed to identify studies (time-period: 2013–2018; geographic
scope: United States, United Kingdom, France, Germany, Italy, Spain, Canada, Australia
and Europe; English only publications). Studies were included if they reported on people liv-
ing with HIV or those at risk of acquiring HIV and used interventions consistent with the
EBIs. A broad range of study designs and methods were searched, including hybrid
designs. Overall, 118 publications covering 225 interventions consistent with the EBIs were
identified. These interventions were evaluated on implementation (N = 183), effectiveness
(N = 81), or both outcomes (N = 39). High variability in the methodological approaches
was observed. Implementation outcomes were frequently evaluated but use of theoretical
frameworks was limited (N = 13). Evaluations undertaken to assess effectiveness were
inconsistent, resulting in a range of measures. This review revealed extensive reporting on
implementation science as defined using evaluation outcomes. However, high variability
was observed in how implementation outcomes and effectiveness were defined, quantified,
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Introduction
To accelerate progress toward ending acquired immunodeficiency syndrome (AIDS) as a pub-
lic health threat by 2030, the Joint United Nations Program on HIV/AIDS (UNAIDS) estab-
lished the 90-90-90 targets [1]. These ambitious targets aim to diagnose 90% of all people
living with HIV (PLHIV), provide antiretroviral therapy (ART) for 90% of those diagnosed
and achieve virological suppression in 90% of those treated with ART by 2020. In 2017, an esti-
mated 75% of PLHIV knew their HIV-positive status, of which an estimated 79% were receiv-
ing ART among whom 81% were virologically suppressed [1]. Recent epidemiological
estimates and programme data from 168 countries in all regions reveal progress but persistent
gaps across the HIV care continuum remain [1, 2]. The HIV care continuum constitutes
sequential steps of medical care from HIV awareness and prevention to the achievement of
virological suppression [2]. To achieve virological suppression, PLHIV need to know their
HIV-infection status, be linked and engaged in care, and receive and adhere to the prescribed
ART regimen. Effective evidence-based interventions (EBIs) are available for all steps along
the HIV care continuum and have been implemented in different geographic settings and con-
texts with success [2]. Despite a global downward trend in the epidemic, progress along the
continuum is variable and several regions are experiencing increases in new infections and a
lack of progress toward the UNAIDS 90-90-90 targets [1]. Globally, as of 2017 only 47% of all
PLHIV achieved virological suppression, which is far lower than the target of 73%, suggesting
many regions are not on track to meet the 2020 target [1].
In order to support the UNAIDS 90-90-90 initiative across diverse contexts, it is essential to
identify appropriate EBIs (i.e. relevant for settings given local epidemiology and health infra-
structure), understand which EBIs are effective and how these can be implemented, scaled and
replicated from single trials of local innovations to broad-scale use [3–5]. This is a recognized
goal of implementation science [6]. Poorly specified and evaluated implementation strategies
present challenges to those who seek to reproduce or scale up the intervention in different set-
tings and contexts and potentially impede real-world adoption of the EBIs [6].
ViiV Healthcare’s Positive Pathways initiative was developed with the overall objective to
support the achievement of the UNAIDS 90-90-90 targets [7], by understanding current evi-
dence-based practice in HIV care in real-world settings [7, 8]. This initiative set out to identify
current EBIs along the HIV care continuum in centres across multiple geographies. The first
phase of the Positive Pathways initiative was to map EBIs in high-income countries and
develop a compendium of EBIs across the HIV care continuum as well as a self-assessment
questionnaire. EBIs were thematically grouped and prioritised in terms of potential impact
and practicality. A final compendium of 21 EBIs across six key themes of current HIV practice
was established (Fig 1; for more details on the development of the Positive Pathways initiative
refer to S1 Fig). The aim was to share the compendium and questionnaire with other HIV care
centres to support the delivery of EBIs to increase prevention, diagnosis, linkage to care and
retention in care.
During the development stage of the Positive Pathways initiative, it became apparent that
effective knowledge transfer to share and embed EBIs in real-world settings would benefit
from an implementation science approach. Implementation science is defined in the HIV
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Lancet as a ‘multidisciplinary specialty that seeks generalisable knowledge about the behaviour
of stakeholders, organisations, communities, and individuals to understand the scale of, rea-
sons for, and strategies to close the gap between evidence and routine practice for health in
real-world contexts’ [9].
Before expanding the Positive Pathways initiative to other geographical regions, we sought
to understand the extent to which identified EBIs were evaluated using implementation sci-
ence within the targeted geographical area. To better understand the current use of implemen-
tation science in HIV care, only a selected set of EBIs were considered for this review. From
the compendium of 21 EBIs, 12 were prioritized by an expert panel across six key themes of
current HIV practice (interventions shaded under each of the six themes). Prioritization was
based on a consideration of feasibility/perceived ease for care centres to trial the EBI. These 12
EBIs are expected to be more widely used, investigated and reported (Fig 1).
This information was considered instrumental in engaging care centres in the choice and
adaptation of EBIs to their respective settings. Practically, given the focus on evaluation, stud-
ies using implementation outcome measures and related study designs may provide a broad
appreciation for the use of implementation science in HIV care. Also, as implementation out-
comes are key intermediate results in relation to clinical effectiveness, measures of effective-
ness are also important to considering the use of implementation science.
Therefore, using measures and methods aligned with implementation science, we set out to
summarise and critically appraise the evidence to obtain a better understanding of the current
state of implementation science in HIV in high-income countries.
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Fig 1. Positive pathways initiative: Compendium of 21 EBIs With 12 prioritised EBIs. From the compendium of 21 interventions, 12 were prioritized by an
expert panel across six key themes of current HIV practice (interventions shaded under each of the six themes). Prioritization was based on a consideration of
feasibility/perceived ease for care centres to trial the EBI. These EBIs are expected to be more widely used, investigated and reported. These 12 EBIs from the Positive
Pathways initiative were included in the scope of the review. For details on the development of the compendium, refer to S1 Fig. ART, antiretroviral therapy; EBI,
evidence-based intervention; HIV, human immunodeficiency virus; PrEP, pre-exposure prophylaxis.
https://doi.org/10.1371/journal.pone.0220060.g001
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Methods
The review focused on 12 EBIs (Fig 1; refer to S1 Fig for more information) and was conducted
according to guidelines in the Cochrane Handbook for Systematic Reviews of Interventions
[10] and Preferred Reporting Items for Systematic Literature Reviews and Meta-Analyses
(PRISMA) [11] to obtain relevant information using a reproducible, robust and transparent
methodology. In-line with these guidelines, we developed a study protocol in which the search
strategy and study eligibility criteria were established prior to conducting the review. After
this, searches were performed and retrieved publications were assessed for eligibility in a two-
phase screening process based on predefined eligibility criteria. From the final list of publica-
tions considered relevant for this review, addata were extracted, the scope of which was also
established a priori. As the final step, we synthesised key findings from the data. The review
methodology is detailed below.
Search sources and strategy
Given the objective of this review, we searched the following 10 databases: Medline, Embase,
ABI/INFORM, Adis Pharmacoeconomic & Outcomes News, Allied and Complementary
Medicine, DH-DATA: Health Administration Medical Toxicology and Environmental Health,
Gale Group Health Periodicals Database, Lancet titles, New England Journal of Medicine, and
Cochrane Central Register of Controlled Trials [12–21]. In the literature search strategy, we
included both free-text and Emtree/MeSH terms for HIV, the 12 EBIs (Fig 1) and implementa-
tion outcomes. The search terms for implementation science were identified from previously
published literature [6, 22, 23]. Hickey et al. [6] was used as the basis for the development phase
of this study whereas Proctor et al. [23] was used to derive relevant implementation and service
outcome search terms. This taxonomy [23] was chosen to guide the review as it is a widely used
evaluation framework in the field of implementation science. Also, given the clear link between
these outcomes and the evaluation of implementation strategies, the review was expected to be
sensitive to detecting any research potentially aligned with implementation science. Also, Cur-
ran et al. [22] was used to identify relevant study designs for inclusion. As this review focused
both on implementation and service (e.g. effectiveness) outcomes, we considered it appropriate
to include hybrid study designs to be able to capture relevant publications for this review [22].
We searched the databases simultaneously via ProQuest [24], with the exclusion of the
Cochrane Central Register of Controlled Trials Database which was searched via the Cochrane
Library [25] (Search date: 29 March 2018). We applied different limits to the searches. This
included restricting the geographical scope of the review to studies conducted in the United States,
United Kingdom, France, Germany, Italy Spain, Canada, Australia, and Europe. This was done
because the EBIs resulting from the Positive Pathways initiative involved only high-income coun-
tries. Furthermore, the review was restricted to English only publications and publication year
from 2013 to 2018. Considering the fact that implementation science is an emerging field within
HIV with guidance published in 2011 and 2012 to advance the understanding of implementation
science [22, 23], the search timeframe of five years was deemed appropriate by the authors to iden-
tify relevant publications (for full details on the search strategy refer to S1 Table).
Inclusion and exclusion criteria
Eligibility criteria for this review are provided in Table 1. In this review, publications were eligi-
ble if they reported on PLHIV or individuals at risk of being infected with HIV and who received
an intervention that could be categorised into the 12 EBIs (Fig 1; refer to S1 Fig for more infor-
mation). For inclusion it was required that the publication reported on outcomes related to the
implementation, effectiveness or both, of the intervention. Including both implementation and
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effectiveness outcomes as per Proctor and colleagues [23] allowed for a review that was compre-
hensive in scope and could produce the most accurate overview of implementation science in
the targeted countries. Implementation outcomes were determined using Proctor et al.’s taxon-
omy [23]. The effectiveness outcomes of interest (i.e. linkage to care, retention in care and medi-
cation adherence) were chosen because of their key role in achieving the UNAIDS 90-90-90
targets. We considered a broad range of study designs for inclusion including observational and
experimental study designs (such as randomised controlled trial [RCT]), qualitative study
designs (such as focus groups and interviews) as well as hybrid study designs which combine
attributes of both quantitative and qualitative data collection.
Screening and selection
After the searches were performed, identified publications were screened in two phases, with
reviews divided between three reviewers (LN, MB and NB). The first phase included screening
Table 1. Inclusion and exclusion criteria.
Inclusion Criteria Exclusion Criteria
Population Human beings infected by HIV
Human beings having AIDS
Human beings with high risk of being infected by HIV
Subjects are not human beings
Subjects do not have HIV/AIDS
Subjects not having high risk of being infected by HIV
Intervention The 12 prioritised EBIs of Positive Pathways initiative:
• Regular HIV testing for at risk groups
• Rapid access to testing services
• Rapid ART intervention
• One stop shop model
• Emergency advice service
• Access to mental health services
• Role of the pharmacist
• Role of the care navigators
• Individualised plan of care
• Structured follow-up
• Diagnosis & management of co-infections & co-morbidities
Interventions not according to the inclusion criteria, for example:
• HIV/AIDS treatment being investigated only in the clinical trial setting
• HIV/AIDS management model only been developed theoretically and not yet
implemented in the real-world setting
Outcome Implementation science outcomes from Proctor et al [23]:
• Adoption
• Acceptability
• Appropriateness
• Feasibility
• Fidelity
• Penetration
• Sustainability
• Implementation costs
Other outcomes with regard to effectiveness of the
interventions, such as:
• Linkage to care
• Adherence
• Retention to care
Outcomes other than those defined in the inclusion criteria
Study Design Review paper
Quantitative studies and qualitative studies (such as RCTs and
observational studies)
Hybrid (type 1 and type 2) studies from Curran et al. [22]
Meta-analysis
Letter to editor
Newspaper
Editorial
Comment
Opinion paper
Geographic
Scope
Europe (continent), EU5 (UK, Germany, France, Italy, Spain),
USA, Canada, Australia
Areas other than those specified in the inclusion criteria
AIDS, acquired immunodeficiency syndrome; ART, antiretroviral therapy; EBI, evidence-based intervention; HIV, human immunodeficiency virus; RCT, randomised
controlled trial.
https://doi.org/10.1371/journal.pone.0220060.t001
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of titles and abstracts of all publications based on the eligibility criteria followed by a second
phase which included reviewing the full-texts of articles using the same criteria (Table 1).
Data extraction and descriptive analyses
After we identified the eligible publications for this review, one reviewer (AO, NB, MB)
extracted the relevant data from these publications. A second reviewer (LN) quality checked
the data extracted. Discrepancies were resolved through discussion and consensus between the
reviewers. We determined data extraction parameters a priori and included intervention
details (e.g. type of intervention, including category of EBI, location of intervention, target
population), implementation outcomes (e.g. parameter assessed, methodology of assessment,
use of a theoretical framework and reported values of the parameter assessed) and effectiveness
outcomes (i.e. linkage to care, retention to care and medication adherence). Transferable
implementation strategies are required to ensure the consistent use of evidence to change
healthcare policy and practice, therefore theoretical frameworks play a key role in implementa-
tion science [26, 27]. Given the number of theoretical frameworks available to evaluate the
implementation of EBIs, we considered it most appropriate to focus on the taxonomy of imple-
mentation outcomes as defined by Proctor et al. [23]. However, we included theoretical frame-
works as a relevant parameter for data extraction.
In this paper we provide a descriptive overview of the types of EBIs identified using the
extracted dataset. This is followed by a discussion on the distribution of EBIs across three pos-
sible categories of evaluation: evaluation of both implementation and effectiveness, evaluation
of implementation, and evaluation of effectiveness. Also, we provide a description on the
implementation outcomes and effectiveness outcomes that have been documented across the
12 EBI categories. Evaluation of the EBIs using implementation and effectiveness outcomes
are reported separately in the results section. As this review aims to document and better
understand the current state of implementation science in HIV, our results focus primarily on
the identification of documented implementation and service outcomes and the methodolo-
gies used to evaluate the implementation of EBIs. As implementation outcomes are key inter-
mediate results in relation to clinical effectiveness, effectiveness outcomes were included in
this review as secondary outcomes of interest. The description on effectiveness outcomes only
focuses on the identification of documented effectiveness outcomes.
Results
Included studies
A total of 4,241 publications were identified from the databases (Fig 2). After the removal of
duplicates, the title and abstracts of 3,908 publications were screened for eligibility. After
excluding 3,451 publications based on title and abstract screening, 457 full-text publications
were assessed for full-text eligibility based on the pre-specified criteria (see Table 1). A total of
339 publications were excluded after full-text screening. Reasons for exclusion were due to the
study population (n = 13), intervention (n = 106), outcomes (n = 141), study design (n = 34),
geographic scope (n = 44) and language (n = 1). A total of 118 publications were included in
the review [28–145] (refer to S1 File for the list of publications excluded after full-text
screening).
Study and intervention characteristics
From a total of 118 publications, a total of 145 single and combination EBIs were identified.
These 145 interventions were categorised into the 12 prioritised EBI categories resulting in a
Implementation science to optimise HIV care
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total of 225 EBIs (note: number is higher as several interventions involved more than one cate-
gory of the prioritised EBIs). Results from this review are reported for 225 EBIs (N, number of
EBIs).
Most of the 225 EBIs were implemented in the United States (N = 167, 74%) followed by
Australia (N = 21, 9%), Canada (N = 13, 6%), United Kingdom (N = 8, 4%), France (N = 10,
4%), Italy (N = 1, <1%) and Spain (N = 5, 2%). No publications were identified for Germany.
Of the 12 prioritised EBI categories “rapid access to testing services” was the most frequently
implemented EBI (N = 66, 29%) followed by the “role of care navigators” (N = 63, 28%) and
“structured follow up” (N = 35, 16%). A variety of study designs was used for the implementa-
tion and evaluation of EBIs. The majority of the 225 EBIs were implemented and evaluated
using a hybrid study design (N = 94, 42%), followed by quantitative study design (N = 45,
20%), qualitative study design (N = 39, 17%), clinical observational study design (N = 25, 11%)
and RCT study design (N = 22, 10%; Table 2). A detailed overview of study and EBI character-
istics is provided in S2 Table.
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Fig 2. PRISMA flow diagram. PRISMA, Preferred Reporting Items for Systematic Literature Reviews and Meta-
Analyses. †Comprises the records identified via Medline, Embase, ABI/INFORM, Adis Pharmacoeconomic &
Outcomes News, Allied and Complementary Medicine, DH-DATA: Health Administration Medical Toxicology and
Environmental Health, Gale Group Health Periodicals Database, Lancet Titles, and the New England Journal of
Medicine.
https://doi.org/10.1371/journal.pone.0220060.g002
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Table 2. Overview of EBI study characteristics (N = 225; n = 118) [28–145].
Theme Prioritised EBI EBI, N
(%)
Distribution of EBIs (N = 225)
Country,
N
Study Design, N Implementation
Outcome†
Theoretical
Framework
Effectiveness
Outcome†
Enabling high accessibility to
HIV care services
Regular HIV testing for at-
risk groups
11 (5) Australia:
3
Canada: 1
Spain: 1
USA: 6
RCT: 1
Observational
study: 3
Hybrid study: 6
Qualitative study:
1
8 0 4
Rapid access to testing
services
66 (29) Australia:
13
Canada: 5
France: 8
Italy: 1
Spain: 3
UK: 5
USA: 31
RCT: 5
Observational
study: 3
Hybrid study: 36
Qualitative study:
18
Quantitative
study: 4
63 2 16
Rapid ART intervention 2 (1) USA: 2 Observational
study: 2
0 0 2
One-stop-shop model 2 (1) USA: 2 Observational
study: 2
0 0 2
Emergency advice service 0 (0) 0 0 0 0 0
Fostering an open and
transparent environment
Access to mental health
services
7 (3) USA: 7 RCT: 4
Observational
study: 1
Hybrid study: 1
Qualitative study:
1
3 2 6
Creating an optimal care team
model
Role of the pharmacist 8 (4) Australia:
2
Canada: 1
Spain: 1
USA: 4
RCT: 1
Observational
study: 1
Hybrid study: 2
Qualitative study:
4
7 0 1
Role of the care navigators 63 (28) Australia:
3
Canada: 3
France: 2
UK: 2
USA: 53
RCT: 4
Observational
study: 3
Hybrid study: 23
Qualitative study:
12
Quantitative
study: 21
56 5 19
Developing a personalized care
management model
Individualised plan of care 25 (11) Canada: 1
USA: 24
RCT: 3
Hybrid study: 10
Quantitative
study: 12
21 1 9
Tracking and enabling
retention in care
Structured follow-up 35 (16) Canada: 1
UK: 1
USA: 33
RCT: 4
Observational
study: 8
Hybrid study: 13
Qualitative study:
3
Quantitative
study: 7
21 3 19
(Continued)
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Evaluation of EBIs
Fig 3 provides a distribution of the EBIs across the three evaluation categories. Of the 225
EBIs, 144 EBIs were evaluated only on their implementation. “Rapid access to testing services”
(N = 50) and “role of care navigators” in HIV care and management (N = 44) were most often
evaluated exclusively on their implementation. In total, 42 EBIs were evaluated only on their
effectiveness, with the EBIs “structured follow-up” (N = 14) and “role of care navigators”
(N = 7) most commonly documented. In addition, 39 EBIs were evaluated on both implemen-
tation and effectiveness. Of this latter group, “rapid access to testing services” (N = 13) and
“role of care navigators” (N = 12) were most frequently assessed.
Of the 225 EBIs, the majority (N = 183, 81%) were evaluated on their implementation. In
addition, a total of 81 EBIs were evaluated on their effectiveness (see Table 2).
Implementation outcomes. Of the 183 EBIs where implementation was evaluated, 59
EBIs (32%) involved two implementation outcomes, resulting in a total of 242 documented
implementation outcomes. A high level of variability was observed in the definitions of
reported implementation outcomes. For example, one study used fidelity to evaluate whether
the intervention was delivered as intended. Fidelity was defined by two components, exposure
and engagement. The implementers defined exposure as the proportion of text messages sent
successfully, and specified engagement with study text messages as the number of months in
which a requested response to the study text message was received [30]. In another study, fidel-
ity was used to evaluate the quality and adherence of a trained HIV therapist. The implemen-
ters defined quality as the competence of the trained HIV therapist to deliver the intervention
and adherence was defined as the % of the session content provided by the HIV therapist
being aligned with the study protocol [109].
Across the eight implementation outcomes of interest, acceptability (N = 100) and imple-
mentation costs (N = 55) were most often reported. The outcome acceptability was most com-
monly used for “rapid access to testing services” (N = 48) and “role of care navigators”
(N = 22). The assessment of the implementation costs was primarily undertaken in the group
of EBIs focused on the “role of care navigators” (N = 24), “individualised plan of care”
(N = 12) and “structured follow-up” (N = 10; Table 3). The predominance of implementation
Table 2. (Continued)
Theme Prioritised EBI EBI, N
(%)
Distribution of EBIs (N = 225)
Country,
N
Study Design, N Implementation
Outcome†
Theoretical
Framework
Effectiveness
Outcome†
Proactive management of co-
infections and co-morbidities
Diagnosis and
management of co-
infections
2 (1) Canada: 1
USA: 1
Observational
study: 1
Quantitative
study: 1
1 0 1
Diagnosis and
management of co-
morbidities
4 (2) USA: 4 Observational
study: 1
Hybrid study: 3
3 0 2
Total 225
(100)
183 13 81
ART, antiretroviral therapy; EBI, evidence-based intervention; HIV, human immunodeficiency virus; N, number of EBIs identified.
N represents the total number of EBIs included in this review. n represents the number of publications in which these EBIs are evaluated. For study and intervention
characteristics, refer to S2 Table.
†The sum of EBIs evaluated on implementation and EBIs evaluated on effectiveness do not add up to the total number of EBIs in each category as an EBI was counted in
a category if it was at least assessed on any one outcome (i.e., implementation or effectiveness). The categories are not mutually exclusive.
https://doi.org/10.1371/journal.pone.0220060.t002
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cost as an outcome for these EBIs is evident due to the involvement of human resources and
their potential impact on healthcare systems.
Of the 242 implementation outcomes reported, 23 implementation outcomes were evalu-
ated by more than one methodological approach, resulting in a total of 265 reported methodol-
ogies to evaluate the implementation of the EBIs. The methods reported were classified into
three categories: questionnaires, interviews, and frameworks.
A mix of quantitative and qualitative methods was used to assess the implementation of the
EBIs (see Fig 4). For example, in a recent study, the acceptability of an opt-out inpatient HIV
screening at an urban teaching hospital was evaluated by using a questionnaire. To determine
the acceptability and to describe the predictors of acceptance or refusal of HIV opt-out inpa-
tient testing, surveys were offered to two samples: a) adult patients admitted to the hospital
who had been offered an HIV test upon admission over a 3-month period and b) the medical
staff of the hospital who offered the HIV tests. The survey consisted of a 5-point Likert-scale
and multiple-choice questions [55]. In another study, the acceptability of a mobile health inter-
vention to improve HIV care coordination for PLHIV with co-morbidities was evaluated by
applying an interview approach. The first 12 study participants and three peer navigators were
asked for their perceptions about the usefulness of the intervention in a one-on-one, in-depth,
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semi-structured interview [61]. Another example of the use of quantitative methods is a retro-
spective medical record review of patient-level data in an urban academic medical centre that
was used to determine the acceptance rate of HIV testing services and to identify reasons for
declining [121].
As presented in Fig 4, amongst all evaluations, only a small number of evaluations (N = 13)
involved the use of a theoretical framework. Evaluations involving a theoretical framework
were applied to five of the 12 prioritised EBIs, and included: “rapid access to testing services”
(N = 2), “access to mental health services” (N = 2), “role of the care navigators” (N = 5), “indi-
vidualised plan of care” (N = 1) and “structured follow-up” (N = 3). All the EBIs were imple-
mented in the United States, primarily in HIV care clinics (N = 9) and were studies involving
fewer than 200 study participants (N = 10). The EBIs were evaluated using the following
frameworks: Theory of Reasoned Action and Social Cognitive Theory; ADAPTS framework,
Information, Motivation, Behavioural Skills Model; Constant Comparative Method as
described by Glaser and Strauss; Grounded theory analysis by Strauss & Corbin; Health Belief
Model; Theory of Planned Behaviour and Reasoned Action; Trans-Theoretical Model and Pre-
caution Adoption Process Model [35, 46, 61, 64, 104, 107, 133, 136]. All but one of these frame-
works (ADAPTS) originates from disciplines external to implementation science [146] and
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Fig 4. Distribution of methodologies for the evaluation of implementation (N = 242, n = 93) [28, 30, 31, 35, 36, 40, 42, 43, 45, 46, 48–51, 53–58, 60–64, 66–
69, 71, 72, 74, 77–80, 83–94, 96, 97, 99–101, 103, 104, 106–109, 111–114, 116–145]. N represents the total number of implementation outcomes reported. n
represents the number of publications in which these implementation outcomes are reported. †The numbers reported do not add up to the total number of
reported implementation outcomes (N = 242) as multiple methods could be used to evaluate the implementation outcome.
https://doi.org/10.1371/journal.pone.0220060.g004
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provides guidance to researchers to study the implementation of an intervention (see Table 4)
[136].
Effectiveness. In total, 81 EBIs were evaluated on effectiveness outcomes (Table 5).
Among the 81 EBIs, 17 EBIs were evaluated for two effectiveness outcomes and one EBI was
evaluated for three effectiveness outcomes, resulting in a total of 100 effectiveness outcomes
reported overall. Retention in care (N = 42) and linkage to care (N = 41) were more frequently
considered for the evaluation of intervention effectiveness compared to medication adherence
(N = 17). The effectiveness outcomes reported were consistent with the objectives of the identi-
fied EBIs. Evaluation of retention in care was most commonly documented for the following
EBIs: “structured follow-up” (N = 14), “role of care navigators” (N = 12) and “individualised
plan of care” (N = 6). The EBI “rapid access to testing services” (N = 16), “role of care naviga-
tors” (N = 10) and “structured follow-up” (N = 7) were most often evaluated for linkage to
care. Medication adherence was evaluated for EBIs that focused on care management, namely:
“role of care navigators” (N = 5), “individualised plan of care” (N = 4), “structured follow-up”
(N = 4) and “access to mental health services” (N = 3).
Table 4. Overview of frameworks used for the evaluation of implementation (N = 13, n = 8) [35, 46, 61, 64, 104, 107, 133, 136].
EBI Number of EBIs
Evaluated by a
Framework
Implementation
Outcome Assessed
Name of the Framework Setting Country of
Implementation
Population
Size, n
Rapid access to
testing services
2 Acceptability
Fidelity
Sustainability
Theory of Reasoned Action and Social
Cognitive Theory
ADAPTS Framework
Community
Clinic
USA <200
NR†
Access to mental
health services
2 Acceptability
Feasibility
Information, Motivation, Behavioural Skills
Model
Multi-stage formative evaluation framework
Clinic (2x)‡ USA <200 (2x)‡
Role of the care
navigators
5 Feasibility
Acceptability
Sustainability
Information, Motivation, Behavioural Skills
Model (2x)
The Constant Comparative Method as
described by Glaser and Strauss
Grounded theory analysis by Strauss & Corbin
Multi-stage formative evaluation (FE)
framework
Clinic (4x)‡
Hospital
USA <200 (4x)‡
200–500
Individualised
plan of care
1 Acceptability Combination of the Health Belief Model, the
Theory of Planned Behaviour and Reasoned
Action, the Trans-Theoretical Model,
Precaution Adoption Process Model, and the
Information, Motivation, Behavioural Skills
meta-theory
Community USA <200
Structured follow-
up
3 Acceptability
Feasibility
Information, Motivation, Behavioural Skills
Model
Constant Comparative Method as described
by Glaser & Strauss
Combination of the Health Belief Model, the
Theory of Planned Behaviour and Reasoned
Action, the Trans-Theoretical Model,
Precaution Adoption Process Model, and the
Information, Motivation, Behavioural Skills
meta-theory
Clinic (2x)‡
Community
USA <200 (2x)‡
200–500
N represents the total number of EBIs that are evaluation with a framework. n represents the number of publications in which these EBIs are evaluated.
†For this EBI, the number of participants included were not reported.
‡ (x) represents the number of times a specific study characteristic has been observed within the EBI category of interest.
ADAPTS, assessment, deliverables, activate, pretraining, training, sustainability; EBI, evidence-based intervention; HIV, human immunodeficiency virus.
https://doi.org/10.1371/journal.pone.0220060.t004
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Significant levels of variation were observed in the evaluation of effectiveness. This was due
to the lack of standardised measures and definitions for the measurement of effectiveness. As a
result, a wide range of reported measures of effectiveness were observed with too many varia-
tions and inconsistencies to report.
Discussion
With its focus on 12 of the EBIs identified within the Positive Pathways initiative, the findings
of this review provide valuable insights into the current state of implementation science in
real-world HIV care settings. As such, it provides a valuable context for consideration in the
adaptation of EBIs identified in the Positive Pathways initiative, as well as highlighting the
progress that remains in maximizing implementation science within HIV to obtain the biggest
impact, especially with the 90-90-90 initiative.
In this review, we found 118 publications covering 225 EBIs spanning across the 12 priori-
tised EBI categories. Of these EBIs, “rapid access to testing services” was most frequently evalu-
ated followed by “role of care navigators” and “structured follow up”. Of these 225 EBIs, 183
were evaluated on implementation. Significant variability was observed in the definitions of
reported implementation outcomes. The variability in definitions represents a challenge for
implementers to effectively evaluate and understand what EBI works where, how and with
whom, as the reported outcomes are not comparable. Consequently, the challenge to bridge
gaps in the HIV care continuum remains.
Very few implementation outcomes were being considered for the evaluation of EBIs, which
may ultimately limit adaptation of EBIs in the real-world setting. Among the 183 EBIs assessed
for implementation outcomes, acceptability and implementation costs were most commonly eval-
uated, whereas fidelity was rarely reported. This could be attributable to the underlying methods
needed to assess these outcomes. Evaluations of acceptability and implementation costs use meth-
ods familiar to clinical settings, such as questionnaires and data analysis. In contrast, fidelity mea-
sures often require more complex methods, such as an audio and video recording, the
development of tailored checklists, and related analyses to assess healthcare professionals’ adher-
ence to study protocols. A mix of quantitative and qualitative methods were used to evaluate the
EBIs, however, there was a lack of consistent use of methodologies to evaluate the implementation
of EBIs. The variability in reported methodologies suggests that either researchers do not seem to
use implementation science approaches, or this variability is perhaps a consequence of the large
number of available frameworks. Of the reported evaluations, only 13/183 used a theoretical
framework, indicating a knowledge gap in implementation science in HIV. As transferable imple-
mentation strategies are required to ensure the consistent use of evidence to change healthcare
policy and practice, theoretical frameworks play a key role in implementation science [26, 27].
Only one out of the of the eight frameworks identified in this review provides guidance to
researchers to study the implementation of an intervention [136]. The high level of variety in defi-
nitions and methodologies used, the disparity in reported implementation outcomes and the min-
imal use of theoretical frameworks reported in our review suggests that the evaluation of EBIs
along the HIV care continuum is not yet aligned with implementation science principles.
Approximately one-third of EBIs were evaluated on effectiveness, most often on linkage
and retention in care. Given the critical role that linkage to care plays after HIV diagnosis, it
was to be expected that the evaluation of the EBI “rapid access to testing services” was largely
measured using linkage to care. In addition, EBIs with a focus on improving care (such as the
role of care navigators, individualised care plans and diagnosis and management of co-mor-
bidities) were also evaluated for effectiveness. Substantial levels of variation were observed in
the evaluation of effectiveness. Proctor et al. state that implementation outcomes are key
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intermediate results in relation to clinical effectiveness [23]. Given the inconsistent approaches
to assessing implementation, it is not surprising that similar levels of variability were observed
with the evaluation of effectiveness, both in terms of definition and methodology used.
Successful implementation of EBIs to support the HIV care continuum in real-world set-
tings, is essential to achieve UNAIDS 90-90-90 targets. However, this review shows evaluations
of EBIs in real-world settings, either on implementation or effectiveness outcomes, do not
appear to be making optimal use of available implementation science approaches.
These findings corroborate the conclusions of a recent literature review by Hickey et al.[6]
which suggested that researchers and implementers continue to face challenges to transfer
effective EBIs from one setting to another, or scale up the intervention within the same setting.
This could potentially undermine progress toward achieving the UNAIDS 90-90-90 targets.
Implementation researchers need to be able to compare and prioritise effective interventions
that contribute to achieving optimal health outcomes for PLHIV. It could be argued, that with-
out the consistent use of implementation science, challenges remain to effectively close the gap
between evidence and the effective use of EBIs in real-world settings.
We recognise there are limitations to this work. The first phase of the Positive Pathways ini-
tiative was to map EBIs in high-income countries and to develop the compendium and self-
assessment questionnaire. Before expanding to other geographical regions, we wanted to con-
textualise the initial findings with a review to understand the extent to which identified EBIs
were being evaluated using implementation science. Future reviews of this nature could
involve more geographical regions, including low and middle-income countries. Secondly, we
restricted our search to a period of five years (2013–2018) and publications written in English
only which could potentially limit the generalisability of our findings. Thirdly, we did not con-
duct all screening activities with two independent reviewers and did not perform a risk of bias
analysis for the publications included. As this review aims to obtain a better understanding of
the current state of the use of implementation science in HIV and did not aim to evaluate the
quality of reported implementation outcomes and methodologies used for evaluation, a
detailed data analysis was not included. Therefore, having one researcher conduct screening
activities was considered appropriate and a risk of bias analysis not necessary.
Furthermore, this review was not registered in a database for systematic reviews, which
may have influenced the level of transparency of this review. However, this review was con-
ducted according to the guidelines in the Cochrane Handbook for Systematic Reviews of Inter-
ventions [10] and PRISMA [11] which does minimise the risk of bias in the conduct of this
review. In addition, we observed a high level of variability in the definitions used for com-
monly reported implementation outcomes which required us to interpret where the outcome
was best-suited to fit within the taxonomy of the eight Proctor et al. [23] implementation out-
comes. In addition, studies using implementation outcomes as a measurement of evaluation
were considered eligible for inclusion. However, given the sensitive and non-specific nature of
these outcomes, using these outcomes does not mean that implementation science principles
were necessarily applied in a study. Given the objective of this review to identify the current
state of implementation science in HIV, we qualified a broad range of study designs such as
quantitative studies, qualitative studies and hybrid designs, which evaluated either an imple-
mentation or effectiveness outcome, or both to this review. It can be argued whether the eligi-
ble studies were designed according to accurate implementation science principles, but as both
implementation and effectiveness outcomes were of interest for this review, the interrelated
link between the two outcomes, and the limited HIV implementation science literature, publi-
cations that only reported effectiveness outcomes, without an implementation science focus
were also included in this review. For example, an RCT that assessed the retention to care of
HIV patients in a real-world setting was considered eligible for inclusion as it reported an
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effectiveness outcome of interest, even if it did not provide any details about the implementa-
tion of the EBI. Adding to this is the inclusion of all hybrid designs that met inclusion criteria
for this review. Given that the hybrid methodology is relatively new, these types of study
designs remain inconsistently reported by name in the literature. Therefore, studies that
reported both on effectiveness and implementation of EBIs were labelled by the reviewers as
hybrid design studies using the criteria from Curran et al. [22]. This self-labelling approach
may have resulted in misclassification of effectiveness or implementation studies as they may
not actually be that type of study design given the variability in interpretation and understand-
ing of these types of studies. This approach is somewhat subjective, and therefore our assess-
ments may be imperfectly reproducible which is not ideal but is reflective of the current state
of implementation science in HIV care.
Lastly, this review focused on the taxonomy of implementation outcomes of Proctor et al.
[23], as it is widely used and accepted in the field of implementation science for the evaluation
of EBIs. The taxonomy provides a classification of implementation outcomes and is therefore
often considered in theoretical frameworks that focus on the evaluation of implementation sci-
ence strategies. Many other theoretical frameworks and models for determining feasible imple-
mentation strategies are available. Given the number of theoretical frameworks, it was
considered more appropriate to use the taxonomy of Proctor et al. [23] for the search strategy.
The inclusion of theoretical frameworks in the search strategy may have restricted the identifi-
cation of theoretical frameworks and introduce bias. Therefore, in this review only theoretical
frameworks that are aligned with Proctor et al. [23] are considered. Overall, the approach used
in the current paper likely captures studies that do not meet the strict implementation science
criteria. However, we have still captured several implementation studies as evidenced by the
proportion of studies citing the use of a hybrid methodology. Regardless, the lack of consis-
tency in labelling a study as implementation research and adhering to proper methodology
and reporting in HIV studies in this review remains a large problem. This issue highlights the
need for more capacity building in implementation science within HIV research.
Conclusion
This systematic literature review provides an empirical review of implementation science
approaches used to evaluate 12 EBIs in support of the HIV continuum. The learnings from this
review highlight the need for a robust implementation science approach to optimise the use of
EBIs in HIV care. Variability in how implementation science is applied to HIV, as seen in the
ways implementation and effectiveness are evaluated and inconsistency in reporting of measures,
methods and outcomes, needs to be addressed if we are to scale up EBIs in support of achieving
the UNAIDS 90-90-90 targets. The lack of consistency in application reporting of key implemen-
tation science elements found in this study is consistent with the work done in sub-Saharan Africa
[147]. Notably, the field of HIV is behind many other fields with respect to utilizing implementa-
tion science to improve health outcomes. To successfully scale and replicate EBIs in different set-
tings and contexts there is a need to ensure the use of theoretical frameworks and consistent
approaches for the evaluation of implementation outcomes. This will improve understanding of
what EBI works where, how and with whom and will bridge the gaps in the HIV care continuum.
Importantly, the consistent and accurate utilization and reporting of implementation science
components of HIV studies in the future is crucial in our ability to end the epidemic.
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